GOVX
GeoVax Labs IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.67M
P/E Ratio
—
EPS
$-24.74
Beta
3.35
52W High
$34.75
52W Low
$0.96
50-Day MA
$1.42
200-Day MA
$9.06
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
9.65
PEG Ratio
0.00
About GeoVax Labs Inc
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.
Fundamentals
| Revenue (TTM) | $2.49M |
| Gross Profit (TTM) | $-15.63M |
| EBITDA | $-21.57M |
| Operating Margin | -869.00% |
| Return on Equity | -483.80% |
| Return on Assets | -186.60% |
| Revenue/Share (TTM) | $2.60 |
| Book Value | $2.21 |
| Price-to-Book | 0.87 |
| Price-to-Sales (TTM) | 1.48 |
| EV/Revenue | 0.435 |
| EV/EBITDA | 15.26 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $2.89M |
| Float | $2.89M |
| % Insiders | 0.12% |
| % Institutions | 7.75% |
Historical Volatility
HV 10-Day
75.18%
HV 20-Day
70.12%
HV 30-Day
66.45%
HV 60-Day
103.22%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($77.50 target)
3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026